Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Nebuloni

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Acta Oto-Laryngologica|January 1, 1991
Kinetic profile of miocamycin in middle ear fluid and mucosaF Fraschini, F Scaglione, M Falchi, et al.
Journal of Chemotherapy (Florence, Italy)|December 1, 1990
Miocamycin distribution in tonsillar and pulmonary tissues after repeated administrationF Scaglione, M Falchi, R Nebuloni, et al.
Molecular and Clinical Oncology|March 21, 2014
Modified FLOX as first-line chemotherapy for metastatic colorectal cancer patients in the public health system in Brazil: Effectiveness and cost-utility analysisDaniela R Nebuloni, Milena P Mak, Fabiano Hahn Souza, et al.
The Oncologist|June 9, 2019
Regorafenib in Patients with Antiangiogenic-Naïve and Chemotherapy-Refractory Advanced Colorectal Cancer: Results from a Phase IIb TrialRachel P Riechelmann, Luiz S Leite, Giovanni M Bariani, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Acta Oto-Laryngologica|January 1, 1991
Kinetic profile of miocamycin in middle ear fluid and mucosaF Fraschini, F Scaglione, M Falchi, et al.
Journal of Chemotherapy (Florence, Italy)|December 1, 1990
Miocamycin distribution in tonsillar and pulmonary tissues after repeated administrationF Scaglione, M Falchi, R Nebuloni, et al.
Molecular and Clinical Oncology|March 21, 2014
Modified FLOX as first-line chemotherapy for metastatic colorectal cancer patients in the public health system in Brazil: Effectiveness and cost-utility analysisDaniela R Nebuloni, Milena P Mak, Fabiano Hahn Souza, et al.
The Oncologist|June 9, 2019
Regorafenib in Patients with Antiangiogenic-Naïve and Chemotherapy-Refractory Advanced Colorectal Cancer: Results from a Phase IIb TrialRachel P Riechelmann, Luiz S Leite, Giovanni M Bariani, et al.
Pageof 2